MESO — Mesoblast Limited stock price, charts and financials

QT21Mesoblast Limited

Mesoblast Limited (NASDAQ: MESO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
14.80
+0.33+2.28%
OverviewShort InterestFilings
MESOQT21Mesoblast Limited·NASDAQ
14.80+2.28%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 30, 20266-KForeign issuer report
Jul 21, 20266-KForeign issuer report
Jul 15, 20266-KForeign issuer report
Jul 14, 20266-KForeign issuer report
Jul 10, 20266-KForeign issuer report
Jul 09, 20264Statement of changes in beneficial ownership
Jul 01, 20266-KForeign issuer report
Jun 25, 20266-KForeign issuer report
Jun 10, 20266-KForeign issuer report
Apr 30, 20266-KForeign issuer report
Apr 29, 20266-KForeign issuer report
Apr 29, 20263Initial statement of beneficial ownership
Apr 17, 20266-KForeign issuer report
Apr 15, 20266-KForeign issuer report
Apr 13, 20264Statement of changes in beneficial ownership
Apr 10, 20264Statement of changes in beneficial ownership
Apr 08, 20266-KForeign issuer report
Apr 08, 20266-KForeign issuer report
Apr 08, 20266-KForeign issuer report
Apr 08, 20266-KForeign issuer report
Apr 01, 20263Initial statement of beneficial ownership
Apr 01, 20263Initial statement of beneficial ownership
Apr 01, 20263Initial statement of beneficial ownership
Mar 23, 20266-KForeign issuer report
Mar 23, 20263Initial statement of beneficial ownership
#1 / 25 of 274
Page
▼
/ 11